Vitamin D regulates cytokine patterns secreted by dendritic cells to promote differentiation of IL-22-Producing T cells

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Sommer, Andrea ^a   Fabri, Mario ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 4; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D; IL1B PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22; TUMOR NECROSIS FACTOR;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; DRUG POTENCY; HELPER CELL; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNE RESPONSE; INFLAMMATION; LYMPHOCYTE CULTURE; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MONOCYTE; NORMAL HUMAN; PHENOTYPE; SUPERNATANT; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH22 CELL; VITAMIN METABOLISM; CELL CULTURE; CELL DIFFERENTIATION; COCULTURE; CYTOLOGY; GENE EXPRESSION REGULATION; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; SECRETION (PROCESS); TH17 CELL;

CELL DIFFERENTIATION; CELLS, CULTURED; COCULTURE TECHNIQUES; DENDRITIC CELLS; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; INTERLEUKIN-1BETA; INTERLEUKIN-23; INTERLEUKIN-6; INTERLEUKINS; LYMPHOCYTE ACTIVATION; MONOCYTES; T-LYMPHOCYTES; TH17 CELLS; TUMOR NECROSIS FACTOR-ALPHA; VITAMIN D;

EID: 84939123061     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0130395     Document Type: Article

References (84)

1. Murphey K, Travers P, M. W. Innate Immunity. Janweway's Immunobiology. Seventh. New York and London: Garland Publishing Inc; 2008. p. 39-108.
2. Miossec P, Korn T, Kuchroo VK. Interleukin-17 and type 17 helper T cells. N Engl J Med. 2009; 361 (9):888-98. Epub 2009/08/28. doi:10.1056/NEJMra0707449 PMID: 19710487.
3. Eyerich S, Wagener J, Wenzel V, Scarponi C, Pennino D, Albanesi C, et al. IL-22 and TNF-alpha represent a key cytokine combination for epidermal integrity during infection with Candida albicans. Eur J Immunol. 2011; 41(7):1894-901. Epub 2011/04/07. doi:10.1002/eji.201041197 PMID: 21469124.
4. Zenewicz LA, Flavell RA. Recent advances in IL-22 biology. Int Immunol. 2011; 23(3):159-63. Epub 2011/03/12. doi:10.1093/intimm/dxr001 PMID: 21393631.
5. Wolk K, Kunz S, Witte E, Friedrich M, Asadullah K, Sabat R. IL-22 increases the innate immunity of tissues. Immunity. 2004; 21(2):241-54. Epub 2004/08/17. doi:10.1016/j.immuni.2004.07.007 PMID: 15308104.
6. Wolk K, Witte E, Wallace E, Docke WD, Kunz S, Asadullah K, et al. IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: A potential role in psoriasis. Eur J Immunol. 2006; 36(5):1309-23. Epub 2006/04/19. doi:10.1002/eji.200535503 PMID: 16619290.
7. Eyerich S, Eyerich K, Pennino D, Carbone T, Nasorri F, Pallotta S, et al. Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J Clin Invest. 2009; 119 (12):3573-85. Epub 2009/11/19. doi:10.1172/jci40202 PMID: 19920355; PubMed Central PMCID: PMC2786807.
8. Mercer F, Khaitan A, Kozhaya L, Aberg JA, Unutmaz D. Differentiation of IL-17-producing effector and regulatory human T cells from lineage-committed naive precursors. J Immunol. 2014; 193(3):1047-54. Epub 2014/06/25. doi:10.4049/jimmunol.1302936 PMID: 24958901; PubMed Central PMCID: PMC4108575.
9. Zielinski CE, Mele F, Aschenbrenner D, Jarrossay D, Ronchi F, Gattorno M, et al. Pathogen-induced human TH17 cells produce IFN-gamma or IL-10 and are regulated by IL-1beta. Nature. 2012; 484 (7395):514-8. Epub 2012/04/03. doi:10.1038/nature10957 PMID: 22466287.
10. Rutz S, Wang X, Ouyang W. The IL-20 subfamily of cytokines-from host defence to tissue homeostasis. Nat Rev Immunol. 2014; 14(12):783-95. Epub 2014/11/26. doi:10.1038/nri3766 PMID: 25421700.
11. Jin W, Dong C. IL-17 cytokines in immunity and inflammation.
12. Manetti R, Parronchi P, Giudizi MG, Piccinni MP, Maggi E, Trinchieri G, et al. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J Exp Med. 1993; 177(4):1199-204. Epub 1993/04/01. PMID: 8096238; PubMed Central PMCID: PMC2190961.
13. Hsieh CS, Macatonia SE, Tripp CS, Wolf SF, O'Garra A, Murphy KM. Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science. 1993; 260(5107):547-9. Epub 1993/04/23. PMID: 8097338.
14. De Jong R, Altare F, Haagen IA, Elferink DG, de Boer T, van Breda Vriesman PJC, et al. Severe mycobacterial and salmonella infections in interleukin-12 receptor-deficient patients. Science. 1998; 280:1435-8. PMID: 9603733.
15. Altare F, Durandy A, Lammas D, Emile JF, Lamhamedi S, Le Deist F, et al. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science. 1998; 280:1432-5. PMID: 9603732.
16. Volpe E, Servant N, Zollinger R, Bogiatzi SI, Hupe P, Barillot E, et al. A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T (H)-17 responses. NatImmunol. 2008; 9(6):650-7. doi:10.1038/ni.1613 PMID: 18454150.
17. Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. NatImmunol. 2007; 8(9):942-9. PMID: 17676045.
18. Wilson NJ, Boniface K, Chan JR, McKenzie BS, Blumenschein WM, Mattson JD, et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. NatImmunol. 2007; 8 (9):950-7. PMID: 17676044.
19. Manel N, Unutmaz D, Littman DR. The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat. NatImmunol. 2008; 9(6):641-9. doi:10.1038/ni.1610 PMID: 18454151.
20. Chen Z, Tato CM, Muul L, Laurence A, O'Shea JJ. Distinct regulation of interleukin-17 in human T helper lymphocytes. Arthritis Rheum. 2007; 56(9):2936-46. Epub 2007/09/01. doi:10.1002/art.22866 PMID: 17763419; PubMed Central PMCID: PMC2323677.
21. Van Beelen AJ, Zelinkova Z, Taanman-Kueter EW, Muller FJ, Hommes DW, Zaat SA, et al. Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells. Immunity. 2007; 27(4):660-9. Epub 2007/10/09. doi:10.1016/j.immuni.2007. 08.013 PMID: 17919942.
22. Evans HG, Suddason T, Jackson I, Taams LS, Lord GM. Optimal induction of T helper 17 cells in humans requires T cell receptor ligation in the context of Toll-like receptor-activated monocytes. Proc- NatlAcadSciUSA. 2007; 104(43):17034-9. PMID: 17942669.
23. Duhen T, Geiger R, Jarrossay D, Lanzavecchia A, Sallusto F. Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat Immunol. 2009; 10(8):857-63. Epub 2009/07/07. doi:10.1038/ni.1767 PMID: 19578369.
24. Zheng Y, Danilenko DM, Valdez P, Kasman I, Eastham-Anderson J, Wu J, et al. Interleukin-22, a T(H) 17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature. 2007; 445 (7128):648-51. PMID: 17187052.
25. Ouyang W, Kolls JK, Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity. 2008; 28(4):454-67. Epub 2008/04/11. doi:10.1016/j.immuni.2008.03.004 PMID: 18400188; PubMed Central PMCID: PMC3424508.
26. McGeachy MJ, Bak-Jensen KS, Chen Y, Tato CM, Blumenschein W, McClanahan T, et al. TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat Immunol. 2007; 8(12):1390-7. Epub 2007/11/13. doi:10.1038/ni1539 PMID: 17994024.
27. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity. 2006; 24 (2):179-89. PMID: 16473830.
28. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006; 441(7090):235-8. PMID: 16648838.
29. Trifari S, Kaplan CD, Tran EH, Crellin NK, Spits H. Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells. Nat Immunol. 2009; 10(8):864-71. Epub 2009/07/07. doi:10.1038/ni.1770 PMID: 19578368.
30. Leung JM, Davenport M, Wolff MJ, Wiens KE, Abidi WM, Poles MA, et al. IL-22-producing CD4+ cells are depleted in actively inflamed colitis tissue. Mucosal Immunol. 2014; 7(1):124-33. Epub 2013/05/23. doi:10.1038/mi.2013.31 PMID: 23695510; PubMed Central PMCID: PMC3870042.
31. Klechevsky E, Banchereau J. Human dendritic cells subsets as targets and vectors for therapy. Ann N Y Acad Sci. 2013; 1284:24-30. Epub 2013/05/09. doi:10.1111/nyas.12113 PMID: 23651190.
32. Hewison M. Vitamin D and innate and adaptive immunity. Vitam Horm. 2011; 86:23-62. Epub 2011/03/23. doi:10.1016/b978-0-12-386960-9.00002-2 PMID: 21419266.
33. Holick MF, MacLaughlin JA, Clark MB, Holick SA, Potts JT Jr., Anderson RR, et al. Photosynthesis of previtamin D3 in human skin and the physiologic consequences. Science. 1980; 210(4466):203-5. Epub 1980/10/10. PMID: 6251551.
34. Lehmann B, Genehr T, Knuschke P, Pietzsch J, Meurer M. UVB-induced conversion of 7-dehydrocholesterol to 1alpha, 25-dihydroxyvitamin D3 in an in vitro human skin equivalent model. J Invest Dermatol. 2001; 117(5):1179-85. Epub 2001/11/17. doi:10.1046/j.0022-202x.2001.01538.x PMID: 11710930.
35. Lehmann B, Rudolph T, Pietzsch J, Meurer M. Conversion of vitamin D3 to 1alpha, 25-dihydroxyvitamin D3 in human skin equivalents. Exp Dermatol. 2000; 9(2):97-103. Epub 2000/04/20. PMID: 10772383.
36. Bikle DD. Vitamin D: newly discovered actions require reconsideration of physiologic requirements. Trends Endocrinol Metab. 2010; 21(6):375-84. Epub 2010/02/13. doi: S1043-2760(10)00005-6 [pii] doi:10.1016/j.tem.2010.01.003 PMID: 20149679; PubMed Central PMCID: PMC2880203.
37. Fritsche J, Mondal K, Ehrnsperger A, Andreesen R, Kreutz M. Regulation of 25-hydroxyvitamin D3-1 alpha-hydroxylase and production of 1 alpha, 25-dihydroxyvitamin D3 by human dendritic cells. Blood. 2003; 102(9):3314-6. Epub 2003/07/12. doi:10.1182/blood-2002-11-3521 PMID: 12855575.
38. Szeles L, Keresztes G, Torocsik D, Balajthy Z, Krenacs L, Poliska S, et al. 1, 25-dihydroxyvitamin D3 is an autonomous regulator of the transcriptional changes leading to a tolerogenic dendritic cell phenotype. J Immunol. 2009; 182(4):2074-83. Epub 2009/02/10. doi:10.4049/jimmunol.0803345 PMID: 19201860.
39. Jeffery LE, Wood AM, Qureshi OS, Hou TZ, Gardner D, Briggs Z, et al. Availability of 25-Hydroxyvitamin D3 to APCs Controls the Balance between Regulatory and Inflammatory T Cell Responses. J Immunol. 2012; 189(11):5155-64. Epub 2012/10/23. doi:10.4049/jimmunol.1200786 PMID: 23087405; PubMed Central PMCID: PMC3504609.
40. Sigmundsdottir H, Pan J, Debes GF, Alt C, Habtezion A, Soler D, et al. DCs metabolize sunlightinduced vitamin D3 to 'program' T cell attraction to the epidermal chemokine CCL27. Nat Immunol. 2007; 8(3):285-93. Epub 2007/01/30. doi:10.1038/ni1433 PMID: 17259988.
41. Pillai S, Bikle DD, Elias PM. 1, 25-Dihydroxyvitamin D production and receptor binding in human keratinocytes varies with differentiation. J Biol Chem. 1988; 263(11):5390-5. Epub 1988/04/15. PMID: 2451669.
42. MacLaughlin JA, Castonguay MA, Holick MF. Cultured human keratinocytes cannot metabolize vitamin D3 to 25-hydroxyvitamin D3. FEBS Lett. 1991; 282(2):409-11. Epub 1991/05/06. PMID: 1645286.
43. Schuessler M, Astecker N, Herzig G, Vorisek G, Schuster I. Skin is an autonomous organ in synthesis, two-step activation and degradation of vitamin D(3): CYP27 in epidermis completes the set of essential vitamin D(3)-hydroxylases. Steroids. 2001; 66(3-5):399-408. Epub 2001/02/17. PMID: 11179749.
44. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, et al. Toll-like receptor triggering of a vitamin Dmediated human antimicrobial response. Science. 2006; 311(5768):1770-3. PMID: 16497887.
45. Fabri M, Stenger S, Shin DM, Yuk JM, Liu PT, Realegeno S, et al. Vitamin D is required for IFNgamma- mediated antimicrobial activity of human macrophages. Sci Transl Med. 2011; 3(104):104ra2. Epub 2011/10/15. doi:10.1126/scitranslmed.3003045 PMID: 21998409.
46. Peelen E, Knippenberg S, Muris AH, Thewissen M, Smolders J, Tervaert JW, et al. Effects of vitamin D on the peripheral adaptive immune system: A review. Autoimmun Rev. 2011; 10(12):733-43. Epub 2011/05/31. doi:10.1016/j.autrev.2011.05.002 PMID: 21621002.
47. Chamorro S, Garcia-Vallejo JJ, Unger WW, Fernandes RJ, Bruijns SC, Laban S, et al. TLR triggering on tolerogenic dendritic cells results in TLR2 up-regulation and a reduced proinflammatory immune program. J Immunol. 2009; 183(5):2984-94. Epub 2009/08/04. doi:10.4049/jimmunol.0801155 PMID: 19648269.
48. Pedersen AW, Holmstrom K, Jensen SS, Fuchs D, Rasmussen S, Kvistborg P, et al. Phenotypic and functional markers for 1alpha, 25-dihydroxyvitamin D(3)-modified regulatory dendritic cells. Clin Exp Immunol. 2009; 157(1):48-59. Epub 2009/08/08. doi:10.1111/j.1365-2249.2009.03961.x PMID: 19659770; PubMed Central PMCID: PMC2710592.
49. Penna G, Adorini L. 1 Alpha, 25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. JImmunol. 2000; 164 (5):2405-11. PMID: 10679076.
50. Hewison M, Freeman L, Hughes SV, Evans KN, Bland R, Eliopoulos AG, et al. Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J Immunol. 2003; 170 (11):5382-90. PMID: 12759412.
51. Van der Aar AM, Sibiryak DS, Bakdash G, van Capel TM, van der Kleij HP, Opstelten DJ, et al. Vitamin D3 targets epidermal and dermal dendritic cells for induction of distinct regulatory T cells. J Allergy Clin Immunol. 2011; 127(6):1532-40 e7. Epub 2011/04/19. doi:10.1016/j.jaci.2011.01.068 PMID: 21497886.
52. Griffin MD, Lutz W, Phan VA, Bachman LA, McKean DJ, Kumar R. Dendritic cell modulation by 1alpha, 25 dihydroxyvitamin D3 and its analogs: A vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. ProcNatlAcadSciUSA. 2001; 98(12):6800-5. PMID: 11371626.
53. Kleijwegt FS, Laban S, Duinkerken G, Joosten AM, Zaldumbide A, Nikolic T, et al. Critical role for TNF in the induction of human antigen-specific regulatory T cells by tolerogenic dendritic cells. J Immunol. 2010; 185(3):1412-8. Epub 2010/06/25. doi:10.4049/jimmunol.1000560 PMID: 20574005.
54. Unger WW, Laban S, Kleijwegt FS, van der Slik AR, Roep BO. Induction of Treg by monocyte-derived DC modulated by vitamin D3 or dexamethasone: differential role for PD-L1. Eur J Immunol. 2009; 39 (11):3147-59. Epub 2009/08/19. doi:10.1002/eji.200839103 PMID: 19688742.
55. Van Halteren AG, van Etten E, de Jong EC, Bouillon R, Roep BO, Mathieu C. Redirection of human autoreactive T-cells Upon interaction with dendritic cells modulated by TX527, an analog of 1, 25 dihydroxyvitamin D(3). Diabetes. 2002; 51(7):2119-25. Epub 2002/06/28. PMID: 12086941.
56. Pludowski P, Holick MF, Pilz S, Wagner CL, Hollis BW, Grant WB, et al. Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-a review of recent evidence. Autoimmun Rev. 2013; 12(10):976-89. Epub 2013/04/02. doi:10.1016/j.autrev.2013.02.004 PMID: 23542507.
57. Hijnen D, Knol EF, Gent YY, Giovannone B, Beijn SJ, Kupper TS, et al. CD8(+) T cells in the lesional skin of atopic dermatitis and psoriasis patients are an important source of IFN-gamma, IL-13, IL-17, and IL-22. J Invest Dermatol. 2013; 133(4):973-9. Epub 2012/12/12. doi:10.1038/jid.2012.456 PMID: 23223131; PubMed Central PMCID: PMC3835628.
58. Fujita H, Nograles KE, Kikuchi T, Gonzalez J, Carucci JA, Krueger JG. Human Langerhans cells induce distinct IL-22-producing CD4+ T cells lacking IL-17 production. Proc Natl Acad Sci U S A. 2009; 106 (51):21795-800. Epub 2009/12/10. doi:10.1073/pnas.0911472106 PMID: 19996179; PubMed Central PMCID: PMC2799849.
59. Kuang DM, Xiao X, Zhao Q, Chen MM, Li XF, Liu RX, et al. B7-H1-expressing antigen-presenting cells mediate polarization of protumorigenic Th22 subsets. J Clin Invest. 2014; 124(10):4657-67. Epub 2014/09/23. doi:10.1172/jci74381 PMID: 25244097; PubMed Central PMCID: PMC4191045.
60. Wobke TK, Sorg BL, Steinhilber D. Vitamin D in inflammatory diseases. Front Physiol. 2014; 5:244. Epub 2014/07/30. doi:10.3389/fphys.2014.00244 PMID: 25071589; PubMed Central PMCID: PMC4078458.
61. Beutler B, Cerami A. Cachectin and tumour necrosis factor as two sides of the same biological coin. Nature. 1986; 320:584-7. PMID: 3010124.
62. Basu R, O'Quinn DB, Silberger DJ, Schoeb TR, Fouser L, Ouyang W, et al. Th22 cells are an important source of IL-22 for host protection against enteropathogenic bacteria. Immunity. 2012; 37(6):1061-75. Epub 2012/12/04. doi:10.1016/j.immuni.2012.08.024 PMID: 23200827; PubMed Central PMCID: PMC3678257.
63. Aujla SJ, Chan YR, Zheng M, Fei M, Askew DJ, Pociask DA, et al. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. NatMed. 2008; 14(3):275-81.
64. Nurieva R, Yang XO, Martinez G, Zhang Y, Panopoulos AD, Ma L, et al. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature. 2007; 448(7152):480-3. PMID: 17581589.
65. Verway M, Bouttier M, Wang TT, Carrier M, Calderon M, An BS, et al. Vitamin D induces interleukin- 1beta expression: paracrine macrophage epithelial signaling controls M. tuberculosis infection. PLoS Pathog. 2013; 9(6):e1003407. Epub 2013/06/14. doi:10.1371/journal.ppat.1003407 PMID: 23762029; PubMed Central PMCID: PMC3675149.
66. Watts C, West MA, Zaru R. TLR signalling regulated antigen presentation in dendritic cells. Curr Opin Immunol. 2010; 22(1):124-30. Epub 2010/01/20. doi:10.1016/j.coi.2009.12.00520083398. PMID: 20083398.
67. Vyas JM, Van der Veen AG, Ploegh HL. The known unknowns of antigen processing and presentation. Nat Rev Immunol. 2008; 8(8):607-18. Epub 2008/07/22. doi:10.1038/nri2368 PMID: 18641646; PubMed Central PMCID: PMC2735460.
68. Krutzik SR, Tan B, Li H, Ochoa MT, Liu PT, Sharfstein SE, et al. TLR activation triggers the rapid differentiation of monocytes into macrophages and dendritic cells. NatMed. 2005; 11:653-60. PMID: 15880118.
69. Schenk M, Krutzik SR, Sieling PA, Lee DJ, Teles RM, Ochoa MT, et al. NOD2 triggers an interleukin- 32-dependent human dendritic cell program in leprosy. Nat Med. 2012; 13:1155-61. doi:10.1038/nm.2650 PMID: 22447076.
70. Piemonti L, Monti P, Sironi M, Fraticelli P, Leone BE, Dal CE, et al. Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. JImmunol. 2000; 164(9):4443-51. PMID: 10779743.
71. Chu CC, Ali N, Karagiannis P, Di Meglio P, Skowera A, Napolitano L, et al. Resident CD141 (BDCA3)+ dendritic cells in human skin produce IL-10 and induce regulatory T cells that suppress skin inflammation. J Exp Med. 2012; 209(5):935-45. Epub 2012/05/02. doi:10.1084/jem.20112583 PMID: 22547651.
72. Berer A, Stockl J, Majdic O, Wagner T, Kollars M, Lechner K, et al. 1, 25-Dihydroxyvitamin D(3) inhibits dendritic cell differentiation and maturation in vitro. Exp Hematol. 2000; 28(5):575-83. Epub 2000/05/17. PMID: 10812248.
73. Boniface K, Bernard FX, Garcia M, Gurney AL, Lecron JC, Morel F. IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes. J Immunol. 2005; 174(6):3695-702. Epub 2005/03/08. PMID: 15749908.
74. Nograles KE, Zaba LC, Guttman-Yassky E, Fuentes-Duculan J, Suarez-Farinas M, Cardinale I, et al. Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways. Br J Dermatol. 2008; 159(5):1092-102. Epub 2008/08/08. doi:10.1111/j.1365-2133.2008.08769.x PMID: 18684158; PubMed Central PMCID: PMC2724264.
75. Sabat R, Ouyang W, Wolk K. Therapeutic opportunities of the IL-22-IL-22R1 system. Nat Rev Drug Discov. 2014; 13(1):21-38. Epub 2014/01/01. doi:10.1038/nrd4176 PMID: 24378801.
76. Sonnenberg GF, Fouser LA, Artis D. Border patrol: Regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. Nat Immunol. 2011; 12(5):383-90. Epub 2011/04/20. doi:10.1038/ni.2025 PMID: 21502992.
77. Liang SC, Tan XY, Luxenberg DP, Karim R, Dunussi-Joannopoulos K, Collins M, et al. Interleukin (IL)- 22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. The Journal of Experimental Medicine. 2006; 203(10):2271-9. PMID: 16982811.
78. Imazeki I, Matsuzaki J, Tsuji K, Nishimura T. Immunomodulating effect of vitamin D3 derivatives on type-1 cellular immunity. Biomed Res. 2006; 27(1):1-9. Epub 2006/03/18. PMID: 16543659.
79. Klug-Micu GM, Stenger S, Sommer A, Liu PT, Krutzik SR, Modlin RL, et al. CD40L and IFN-gamma induce an antimicrobial response against M. tuberculosis in human monocytes. Immunology. 2013; 139(1):121-8. Epub 2013/01/08. doi:10.1111/imm.12062 PMID: 23289765.
80. Campbell GR, Spector SA. Vitamin D inhibits human immunodeficiency virus type 1 and Mycobacterium tuberculosis infection in macrophages through the induction of autophagy. PLoS Pathog. 2012; 8 (5):e1002689. Epub 2012/05/17. doi:10.1371/journal.ppat.1002689 PMID: 22589721; PubMed Central PMCID: PMC3349755.
81. Nikolic T, Roep BO. Regulatory multitasking of tolerogenic dendritic cells-lessons taken from vitamin d3-treated tolerogenic dendritic cells. Front Immunol. 2013; 4:113. Epub 2013/05/30. doi:10.3389/fimmu.2013.00113 PMID: 23717310; PubMed Central PMCID: PMC3653108.
82. Gordon JR, Ma Y, Churchman L, Gordon SA, Dawicki W. Regulatory dendritic cells for immunotherapy in immunologic diseases. Front Immunol. 2014; 5:7. Epub 2014/02/20. doi:10.3389/fimmu.2014.00007 PMID: 24550907; PubMed Central PMCID: PMC3907717.
83. Silverberg MS, Cho JH, Rioux JD, McGovern DP, Wu J, Annese V, et al. Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study. Nat Genet. 2009; 41(2):216- 20. Epub 2009/01/06. doi:10.1038/ng.275 PMID: 19122664; PubMed Central PMCID: PMC2652837.
84. Engelhardt KR, Shah N, Faizura-Yeop I, Kocacik Uygun DF, Frede N, Muise AM, et al. Clinical outcome in IL-10- And IL-10 receptor-deficient patients with or without hematopoietic stem cell transplantation. J Allergy Clin Immunol. 2013; 131(3):825-30. Epub 2012/11/20. doi:10.1016/j.jaci.2012.09.025 PMID: 23158016.